Gastrointestinal pancreatic neuroendocrine neoplasia (GEP-NEN) biomarkers and materials, systems and kits for detecting the same, and related GEP-NEN diagnostic, prognostic and predictive methods and uses thereof, such as therapeutic efficacy and other results, according to the present invention. The use of detecting, predicting, determining, profiling, classifying and monitoring is disclosed.
展开▼
